nach oben

International Urology and Nephrology

Erschienen in:

01.03.2016 | Urology - Review

Updates of underactive bladder: a review of the recent literature

verfasst von: Xing Li, Limin Liao

Erschienen in: International Urology and Nephrology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Underactive bladder (UAB) is a major component of lower urinary tract symptoms. The physiopathology mechanisms underlying UAB include detrusor underactivity, acontractile detrusor, and reduced or absent bladder sensation. UAB can influence lower and upper urinary tract function and lead to serious consequences; however, the symptom syndrome is poorly understood and incompletely researched at present. Moreover, there is no agreement among authorities regarding the terminology, definition, epidemiology, classification, risk factors, animal model, pathogenesis, diagnosis, and treatment of UAB. In this review, we discuss the current terminology, epidemiology, physiopathology, evaluation, and management of UAB.

Abrams P et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187(1):116–126CrossRefPubMed

Chapple CR et al (2015) The underactive bladder: a new clinical concept? Eur Urol 68(3):351–353CrossRefPubMed

Chapple C (2013) Overactive bladder and underactive bladder: a symptom syndrome or urodynamic diagnosis? Neurourol Urodyn 32(4):305–307CrossRefPubMed

Valente S et al (2014) Epidemiology and demographics of the underactive bladder:a cross-sectional survey. Int Urol Nephrol 46(Suppl 1):S7–S10CrossRefPubMed

Taylor JA 3rd, Kuchel GA (2006) Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc 54(12):1920–1932CrossRefPubMed

Tyagi P et al (2014) Pathophysiology and animal modeling of underactive bladder. Int Urol Nephrol 46(Suppl. 1):S11–S21CrossRefPubMedPubMedCentral

Smith PP (2010) Aging and the underactive detrusor: a failure of activity or activation? Neurourol Urodyn 29(3):408–412PubMed

Osman NI et al (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 65(2):389–398CrossRefPubMed

Andersson KE (2014) Bladder underactivity. Eur Urol 65(2):399–401CrossRefPubMed

10.

van Koeveringe GA et al (2011) Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 30(5):723–728CrossRefPubMed

11.

Purohit RS et al (2008) The pathophysiology of large capacity bladder. J Urol 179(3):1006–1011CrossRefPubMed

12.

Eqqilmez T, Resit Goren M (2014) Catheterized uroflowmetry as a noninvasive test for detrusor acontractility. Urol Int 92(3):316–322CrossRef

13.

Stav K et al (2013) Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility. J Urol 189(6):2175–2178CrossRefPubMed

14.

Griffiths DJ et al (2002) Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn 21(2):126–131CrossRefPubMed

15.

Yamamoto T et al (2006) Neurological diseases that cause detrusor hyperactivity with Impaired contractile function. Neurourol Urodyn 25(4):356–360CrossRefPubMed

16.

Liu S, Chan L, Tse V (2014) Clinical outcome in male patients with detrusor overactivity with impaired contractility. Int Neurourol J 18(3):133–137CrossRefPubMedPubMedCentral

17.

Chancellor MB, Kaufman J (2008) Case for pharmacotherapy development for underactive bladder. Urology 72(5):966–967CrossRefPubMed

18.

Underactive bladder foundation 2014. www.underactivebladder.org

19.

Cucchi A et al (2007) Urodynamic findings suggesting two-stage development of idiopathic detrusor underactivity in adult men. Urology 70(1):75–79CrossRefPubMed

20.

Smith PP, Chalmers DJ, Feinn RS (2015) Does defective volume sensation contribute to detrusor underactivity? Neurourol Urodyn 34(8):752–756CrossRefPubMed

21.

Chancellor MB, Diokno A (2014) CURE-UAB: shedding light on the underactive bladder syndrome. Int Urol Nephrol 46(Suppl 1):S1CrossRefPubMed

22.

Suskind AM, Smith PP (2009) A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr Urol Rep 10(5):347–351CrossRefPubMed

23.

Jeong SJ et al (2012) Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol 53(5):342–348CrossRefPubMedPubMedCentral

24.

Abarbanel J, Marcus EL (2007) Impaired detrusor contractility in community dwelling elderly presenting with lower urinary tract symptoms. Urology 69(3):436–440CrossRefPubMed

25.

Diokno AC et al (1986) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136(5):1022–1025PubMed

26.

Belenky A et al (2003) Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction. Urology 62(4):647–650CrossRefPubMed

27.

Thomas AW et al (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated detrusor underactivity. BJU Int 96(9):1295–1300CrossRefPubMed

28.

Lee JG, Shim KS, Koh SK (1999) Incidence of detrusor underactivity in men with prostatism older than 50 years. Korean J Urol 40(3):347–352

29.

Smith PP, Hurtado EA, Appell RA (2009) Post hoc interpretation of urodynamic evaluation is qualitatively different than interpretation at the time of urodynamic study. Neurourol Urodyn 28(8):998–1002CrossRefPubMed

30.

Cucchi A, Quaglini S, Rovereto B (2008) Development of idiopathic detrusor underactivity in women: from isolated decrease in contraction velocity to obvious impairment of voiding function. Urology 71(5):844–848CrossRefPubMed

31.

Kuo HC (2007) Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction. Urology 69(1):57–61CrossRefPubMed

32.

Andersson KE, Arner A (2004) Urinary bladder contraction and relaxation:physiology and pathophysiology. Physiol Rev 84(3):935–986CrossRefPubMed

33.

Oshiro T, Miyazato M, Saito S (2014) Relationship between connexin43-derived gap junction proteins in the bladder and age-related detrusor underactivity in rats. Life Sci 116(1):37–42CrossRefPubMed

34.

Griffiths D et al (2007) Cerebral control of the bladder in normal and urge-incontinent women. Neuroimage 37(1):1–7CrossRefPubMedPubMedCentral

35.

Miyazato M, Yoshimura N, Chancellor MB (2013) The other bladder syndrome: underactive bladder. Rev Urol 15(1):11–22PubMedPubMedCentral

36.

Kalichman L et al (2009) Spinal stenosis prevalence and association with symptoms: the Framingham study. Spine J 9(7):545–550CrossRefPubMedPubMedCentral

37.

Meng NH et al (2010) Incomplete bladder emptying in patients with stroke: Is detrusor external sphincter dyssynergia a potential cause? Arch Phys Med Rehabil 91(7):1105–1109CrossRefPubMed

38.

Campos-Sousa RN et al (2003) Urinary symptoms in Parkinson’s disease: prevalence and associated factors. Arq Neuropsiquiatr 61(2B):359–363CrossRefPubMed

39.

Mesrobian HG (2014) Complete primary repair of bladder exstrophy is associated with detrusor underactivity type of neurogenic bladder. Urology 83(5):1139–1144CrossRefPubMed

40.

Giannantoni A et al (2004) Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol 171(4):1563–1566CrossRefPubMed

41.

Kielb SJ, Clemens JQ (2005) Comprehensive urodynamics evaluation of 146 men with incontinence after radical prostatectomy. Urology 66(2):392–396CrossRefPubMed

42.

Kitta T et al (2015) Postoperative detrusor contractility temporarily decreases in patients undergoing pelvic organ prolapse surgery. Int J Urol 22(2):201–205CrossRefPubMed

43.

Araki I et al (2009) Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct 20(11):1301–1306CrossRefPubMed

44.

Hakvoort RA et al (2009) Predicting short-term urinary retention after vaginal prolapse surgery. Neurourol Urodyn 28(3):225–228CrossRefPubMed

45.

Ouslander JG (2004) Management of overactive bladder. N Engl J Med 350(8):786–799CrossRefPubMed

46.

Bozikas V, Petrikis P, Karavatos A (2001) Urinary retention caused after fluoxetine-risperidone combination. J Psychopharmacol 15(2):142–143CrossRefPubMed

47.

Delgado JH et al (2004) Acute, transient urinary retention from combined ecstasy and methamphetamine use. J Emerg Med 26(2):173–175CrossRefPubMed

48.

Changolkar AK et al (2005) Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 173(1):309–313CrossRefPubMed

49.

Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119(3 Suppl. 1):S3–S8CrossRefPubMed

50.

Sekido N et al (2012) A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model. Neurourol Urodyn 31(7):1190–1196CrossRefPubMed

51.

Jiang HH et al (2013) Bladder dysfunction changes from underactive to overactive after experimental traumatic brain injury. Exp Neurol 240:57–63CrossRefPubMed

52.

Saito M, Miyagawa I (2001) Bladder dysfunction after acute urinary retention in rats. J Urol 165(5):1745–1747CrossRefPubMed

53.

Kim DK et al (2009) Cystometric changes in pressure-guided acute distension rat model of the underactive bladder. Tzu Chi Med J 21(2):136–139

54.

Somogyi GT et al (2002) Effect of cryoinjury on the contractile parameters of bladder strips: a model of impaired detrusor contractility. Brain Res Bull 59(1):23–28CrossRefPubMed

55.

Nomiya M et al (2014) Progressive vascular damage may lead to bladder underactivity in rats. J Urol 191(5):1462–1469CrossRefPubMed

56.

Munoz A et al (2011) Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release. Neurochem Int 58(3):295–300CrossRefPubMed

57.

Young JS et al (2013) The passive and active contractile properties of the neurogenic, underactive bladder. BJU Int 111(2):355–361CrossRefPubMed

58.

Nirmal J et al (2014) Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat. PLoS ONE 9(7):e102644CrossRefPubMedPubMedCentral

59.

Lai HH et al (2007) Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69(2):407–411CrossRefPubMed

60.

van Koeveringe GA et al (2014) Detrusor underactivity: pathophysiological considerations, models and proposals for future research. ICI-RS 2013. Neurourol Urodyn 33(5):591–596CrossRefPubMedPubMedCentral

61.

Ukimura O et al (2003) Ultrasonic measurement of bladder weight as a novel urodynamic modality. Adv Exp Med Biol 539(Pt A):311–315

62.

Chancellor MB (2014) The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol 46(Suppl 1):S23–S27CrossRefPubMed

63.

Cucchi A, Quaglini S, Rovereto B (2010) Different evolution of voiding function in underactive bladders with and without detrusor overactivity. J Urol 183(1):229–233CrossRefPubMed

64.

Casanova N, McGuire E, Fenner DE (2006) Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity. Int J Gynaecol Obstet 95(3):305–311CrossRefPubMed

65.

Bromage SJ et al (2010) Urodynamics in the octogenarian female: Is it worthwhile? Int Urogynecol J 21(9):1117–1121CrossRefPubMed

66.

Schaefer W (1990) Basic principles and clinical application of advanced analysis of bladder voiding function. Urol Clin N Am 17(3):553–566

67.

Liao L, Schaefer W (2009) Within-session reproducibility and variability of urethral resistance and detrusor contractility in pressure-flow studies in men with lower urinary tract symptoms. Curr Urol 3(1):19–28

68.

Griffiths DJ (1991) Assessment of detrusor contraction strength or contractility. Neurourol Urodyn 10(1):1–18CrossRef

69.

Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15CrossRefPubMed

70.

Sullivan MP, Yalla SV (1996) Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction. J Urol 155(6):1995–2000CrossRefPubMed

71.

Schäfer W (1995) Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 13(1):47–58CrossRefPubMed

72.

Cucchi A, Quaglini S, Rovereto B (2009) Proposal for a urodynamic redefinition of detrusor underactivity. J Urol 181(1):225–229CrossRefPubMed

73.

Andersson KE (2010) Detrusor underactivity/underactive bladder: new research initiatives needed. J Urol 184(5):1829–1830CrossRefPubMed

74.

Jhang JF, Jiang YH, Kuo HC (2014) Transurethral Incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity. Int Urogynecol J 25(5):671–676CrossRefPubMed

75.

Barendrecht MM et al (2007) Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int 99(4):749–752CrossRefPubMed

76.

Barrett DM (1981) The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol 126(5):640–642PubMed

77.

Bougas DA et al (2004) Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor. Int Urol Nephrol 36(4):507–512CrossRefPubMed

78.

Dasgupta R (2004) Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int 94(1):191–192CrossRefPubMed

79.

Krishnamoorthy S, Kekre NS (2009) Detrusor underactivity: To tone or not to tone the bladder? Indian J Urol 25(3):407–408CrossRefPubMedPubMedCentral

80.

Rahnama’i MS et al (2012) The role of prostanoids in urinary bladder physiology. Nat Rev Urol 9(5):283–290CrossRefPubMed

81.

Kim JC et al (2005) Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int Urol 12(10):875–880CrossRef

82.

Sakakibara R et al (2000) Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 79(2–3):191–195CrossRefPubMed

83.

Chang SJ, Chiang IN, Yu HJ (2008) The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol 15(11):981–985CrossRefPubMed

84.

Yamanishi T et al (2004) Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11(2):88–96CrossRefPubMed

85.

Yoshii K et al (2011) Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for treatment of functional dyspepsia, in rat stomach. J Pharm Sci 100(11):4965–4973CrossRefPubMed

86.

Sugimoto K et al (2015) A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity. Res Rep Urol 7:81–83PubMedPubMedCentral

87.

Phelan MW et al (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165(4):1107–1110CrossRefPubMed

88.

Mokhless I et al (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol 176(4 Pt 2):1767–1770CrossRefPubMed

89.

Liao YM, Kuo HC (2007) Causes of failed urethral botulinum toxin A treatment for emptying failure. Urology 70(4):763–766CrossRefPubMed

90.

Thorner DA et al (2014) Outcomes of reduction cystoplasty in men with impaired detrusor contractility. Urology 83(4):882–886CrossRefPubMed

91.

Gakis G et al (2011) Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol 185(2):593–599CrossRefPubMed

92.

Moreno-Palacios J et al (2012) Outcomes and complications of sphincterotomy with bladder neck incision in neurologically healthy male patients with voiding dysfunction. Arch Esp Urol 65(2):244–250PubMed

93.

Mhiri MN, Bahloul A, Chabchoub K (2007) Mitrofanoff appendicovesicostomy in children: indication and results. Prog Urol 17(2):245–249CrossRefPubMed

94.

Kari J et al (2013) Is Mitrofanoff a more socially accepted clean intermittent catheterization (CIC) route for children and their families? Eur J Pediatr Surg 23(5):405–410PubMed

95.

Lombardi G et al (2014) Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord 52(3):241–245CrossRefPubMed

96.

Swinn MJ et al (2000) Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol 38(4):439–443CrossRefPubMed

97.

Kavia R et al (2010) A functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler’s syndrome. BJU Int 105(3):366–372CrossRefPubMed

98.

Stöhrer M et al (2009) EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56(1):81–88CrossRefPubMed

Titel: Updates of underactive bladder: a review of the recent literature
verfasst von: Xing Li
Limin Liao
Publikationsdatum: 01.03.2016
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 6/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-016-1251-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

Proteasome or immunoproteasome inhibitors cause apoptosis in human renal tubular epithelial cells under normoxic and hypoxic conditions

Environmental estrogens have an impact on the ERs and their signaling in ER-responsive tissues and organs

The association of endothelial progenitor cell markers with arteriovenous fistula maturation in hemodialysis patients

Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults

Peritoneal dialysis can be an option for unplanned chronic dialysis: initial results from a developing country